Skip to main content
. 2019 Aug 15;11(8):1912. doi: 10.3390/nu11081912

Table 1.

Summary of performance data under the three employed conditions.

Variable Placebo
(95% CI)
CAF-9
(95% CI)
CAF-11
(95% CI)
F p
1RM [kg] 118.3 ± 14.5
(109.4–125.5)
122.3 ± 15.3
(115.7–132.5)
124.2 ± 11.4
(116.3–135.2)
0.24 0.78
T-REP [n] 25.1 ± 3.2
(23.3–26.8)
25.0 ± 4.9
(22.4–27.6)
25.6 ± 3.3
(23.8–27.3)
0.09 0.90
TUTCON [s] 17.1 ± 3.29
(15.3–18.8)
19.1 ± 3.29
(17.3–20.8)
16.9 ± 3.39
(15.1–18.8)
2.01 0.14
MP [W] 348 ± 79
(305–390)
333 ± 72
(294–372)
318 ± 78
(276–360)
0.61 0.54
PP [W] 798 ± 164
(710–886)
766 ± 134
(694–837)
731 ± 186
(632–831)
0.61 0.51
MV [m/s] 0.71 ± 0.10
(0.66–0.76)
0.67 ± 0.08
(0.63–0.72)
0.70 ± 0.07
(0.66–0.74)
0.8 0.45
PV [m/s] 1.39 ± 0.16
(1.31–1.48)
1.37 ± 0.15
(1.29–1.45)
1.25 ± 0.17
(1.16–1.34)
3.43 0.04 *

All data are presented as mean ± standard deviation; CI—confidence interval; * statistically significant difference p < 0.05; 1RM: One repetition maximum; T-REP: Total number of repetitions; TUTCON: Time under tension during concentric movement; MP: Mean power output; PP: Peak power output; MV: Mean velocity; PV: Peak velocity.